Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1207017 NEW YORK, NY

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$41,773,927
+$4,855,331 QoQ
Shares Held
299,734
-0.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 83.67619289103004.ToString("F0")% Shared 0.ToString("F0")% None 16.323807108969955.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

LAZARD ASSET MANAGEMENT LLC holds $2,038,524,902 across 14 Drug Manufacturers - General names. GILD ranks #6 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
299,734 $41,773,927

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $41,773,927 299,734
2025-12-31 $36,918,596 300,787
2025-09-30 $37,458,948 337,468
2025-06-30 $37,832,502 341,233
2025-03-31 $40,970,746 365,647
2024-12-31 $37,001,666 400,581
2024-09-30 $37,237,200 444,146
2024-06-30 $65,932,974 960,982
2024-03-31 $71,032,941 969,733
2023-12-31 $76,558,499 945,050
2023-09-30 $52,340,792 698,436
2023-06-30 $73,002,243 947,220
2023-03-31 $99,497,124 1,199,194
2022-12-31 $72,476,543 844,223
2022-09-30 $32,045,794 519,465
2022-06-30 $24,619,602 398,311
2022-03-31 $12,338,549 207,545
2021-12-31 $13,311,590 183,330
2021-09-30 $803,414 11,502
2021-06-30 $313,037 4,546
2021-03-31 $7,620,199 117,905
2020-12-31 $10,434,073 179,095
2020-09-30 $18,342,034 290,268
2020-06-30 $33,060,963 429,698
2020-03-31 $7,175,539 95,981